期刊文献+

体外研究羟丙甲基纤维素对自微乳化给药系统胃肠道行为的影响

Influence of Hydroxypropylmethylcellulose on Digestion of Self-Microemulsifying Drug Delivery System in Gastro-Intestinal Tract in Vitro
原文传递
导出
摘要 目的探究羟丙甲基纤维素对自微乳化给药系统胃肠道行为的影响,为固体自微乳化给药系统的固体载体选择提供依据。方法采用胃模拟分散试验和体外脂解模型测定3种规格的羟丙甲基纤维素(K4M、K15M、K100M)对自微乳化给药系统胃肠道行为的影响。结果 3种规格的羟丙甲基纤维素都可抑制自微乳化给药系统在胃肠道中的分散沉淀;随着羟丙甲基纤维素的黏度增加,自微乳化给药系统的载药能力增强,小肠脂解后分配进入水相的药物浓度也增加。结论羟丙甲基纤维素有利于自微乳化给药系统中药物在胃肠道的吸收,可作为研制固体自微乳化给药系统的固体载体。 OBJECTIVE To study the influence of different viscosity hydroxypropylmethylcellulose(HPMC) on the digestion of self-microemulsifying drug delivery system(S-SMEDDS) in the gastro-intestinal tract,so as to provide basis for the further development of S-SMEDDS.METHODS In vitro experiments including dispersion experime nt and an in vitro lipolysis model were used to evaluate the influence of HPMC of three viscosity grade(K4M,K15M and K100M) on the digestion of S-SMEDDS in gastrointestinal tract.RESULTS All three kinds of HPMC could inhibit the precipitation of drug in gastro-intestinal tract.With the increasing of HPMC viscosity,the solub drug concentration in aqueous phase after intestinal lipolysis were both increased.CONCLUSION HPMC can improve the gastrointestinal absorption of S-SMEDDS and be used as its solid carrier.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第7期527-531,共5页 Chinese Pharmaceutical Journal
基金 重庆市自然科学基金资助项目(CSTC2009BB5106) 重庆高校优秀成果转化资助项目(KJ08B06) 中央高校基本科研业务费专项资金项目(XDJK2009C076) 西南大学博士基金项目(SWUB2008032)
关键词 羟丙甲基纤维素 自微乳化给药系统 水难溶性药物 分散试验 体外脂解模型 hydroxypropylmethylcellulose self-microemulsifying drug delivery systems poor soluble drugs dispersion tests in vitro lipolysis model
  • 相关文献

参考文献2

二级参考文献34

  • 1[3]罗明生,高天惠.药用辅料大全.成都:四川科技出版社,1993
  • 2Abdalla A, Mader K. Preparation and characterization of a self-emulsifying pellet formulation [ J]. Eur J Pharm Biopharm, 2007, 66(2): 220-226.
  • 3Carrier RL, Miller L A, Ahmed I. The utillty of cyclodextrins for enhancing oral bioavailability [ J ]. J Controlled Release, 2007, 123(2): 78-99.
  • 4Gursoy R N, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs[J]. Biomed Pharmacother , 2004, 58(3) : 173-182.
  • 5Tuleu C, Newton M, Rose J, et al. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progresterone[J]. J Pharm Sci, 2004, 93(6) : 1495-1502.
  • 6Porter C J H, Charman W N. Intestinal lymphatic drug transport: an update[J]. Adv Drug Deliv Rev, 2001, 50(1-2): 61-80.
  • 7Pouton C W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system [ J ]. Eur J Pharm Sci, 2006, 29(3-4): 278-287.
  • 8Newton M, Petersson J, Podczeck F, et al. The influence of formulation variables on the properties of pellets containing a self-emulsifyingmixture[J]. J Pharm Sci, 2001, 90(8): 987-995.
  • 9Patil P, Paradkar A. Porous polystyrene beads as carriers for self-emulsifying system containing loratadine [ J ]. AAPS Pharm Sci Tech, 2006, 7(1): E1-E7.
  • 10Nazzal S, Nutan M, Palamakula A, et al. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients[J]. Int J Pharm, 2002, 240(1-2): 103-114.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部